NCT07560475
- Conditions
- Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Tianjin Medical University Cancer Insititute and Hospital Tianjin, China
Clinical trial condition
Explore clinical trials studying HER2positive. Study availability and eligibility vary by location and protocol.
NCT07560475